[ RadSafe ] Guidance for I-131 Patients

Maury Siskel maurysis at peoplepc.com
Tue Feb 19 12:46:23 CST 2008


Hi Richard,
This may not be the one you want, but this looks pretty relevant .
Cheers,
Maury&Dog

============================
http://tech.snmjournals.org/cgi/content/full/29/2/61

ABSTRACT
TOP
INTRODUCTION
INITIAL PREPARATIONS
PATIENT PREPARATION
DOSE ADMINISTRATION
AREA SURVEYS
PATIENT RELEASE FROM THE...
SOURCES OF ASSISTANCE
REFERENCES

ABSTRACT 
Objectives: The patient who has been dosed with therapeutic activities 
of 131I for thyroid carcinoma poses a unique set of problems for nuclear 
medicine technologists in their efforts to reduce personnel exposure and 
control contamination spread. It is the objective of this article to: 
(a) review practical radiation safety concerns associated with 
hospitalized 131I therapy patients; (b) propose preventative measures 
that can be taken to minimize potential exposure and contamination 
problems; and (c) review pertinent federal regulations that apply to 
patients containing therapeutic levels of radionuclides.

=====================
Hansen, Richard wrote:

>NRC NUREG - 1556, Vol. 9, Rev 2 mentions a pamphlet published by the
>Society of Nuclear Medicine regarding information for patients receiving
>treatment with radioiodine. Does anyone have an electronic version of
>this pamphlet or know where to get one?
>
>
>Quote from 
>NRC NUREG - 1556, Vol. 9, Rev 2, January 2008
>Consolidated Guidance About Materials Licenses Program-Specific Guidance
>About Medical Use Licenses
>
>Appendix U
>Model Procedure for Release of Patients or Human Research Subjects
>Administered Radioactive Materials
>
>Page U-11 (page 400 in PDF file)
>
>http://www.nrc.gov/reading-rm/doc-collections/nuregs/staff/sr1556/v9/r2/
>sr1556v9r2-final.pdf#app-u
>
>The Society of Nuclear Medicine published a pamphlet in 1987 that
>provides information for patients receiving treatment with radioiodine.
>This pamphlet was prepared jointly by the Society of Nuclear Medicine
>and the NRC. The pamphlet contains blanks for the physician to fill in
>the length of time that each instruction should be followed. Although
>this pamphlet was written for the release of patients to whom less than
>1,110 megabecquerels (30 millicuries) of iodine-131 had been
>administered, the NRC still considers the instructions in this pamphlet
>to be an acceptable method for meeting the requirements of 10 CFR
>35.75(b), provided the times filled in
>the blanks are appropriate for the activity and the medical condition.
>
>Thanks,
>
>Rick Hansen
>Senior Scientist
>Counter Terrorism Operations Support Program
>National Security Technologies, LLC, for the U.S. Dept of Energy
>hansenrg at nv.doe.gov
>www.nv.doe.gov/nationalsecurity/homelandsecurity/responder.htm
>
>Snippet:
>
>Date: Sun, 17 Feb 2008 11:02:51 -0800 (PST)
>From: John Jacobus <crispy_bird at yahoo.com>
>Subject: Re: [ RadSafe ] I-131 Patients and Taxi driver
>
>Jerry,
>  The NRC recommends (and everybody generally follows) the restriction
>that a patient being treated with I-131 can be released when the
>exposure rate at 1 meter is 7 mrem/hr. See column 2 on page 394 at
>http://www.nrc.gov/reading-rm/doc-collections/nuregs/staff/sr1556/v9/r2/
>sr1556v9r2-final.pdf#app-u  On page 397, it indicates the instructs are
>to be given when the exposure rate exceeds 2 mrem/hour.
>
>
>_______________________________________________
>You are currently subscribed to the RadSafe mailing list
>
>Before posting a message to RadSafe be sure to have read and understood the RadSafe rules. These can be found at: http://radlab.nl/radsafe/radsaferules.html
>
>For information on how to subscribe or unsubscribe and other settings visit: http://radlab.nl/radsafe/
>
>  
>




More information about the RadSafe mailing list